New treatment option may be on the horizon for polymyalgia rheumatica
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting ...
Nov 10, 2015
0
15